Longitudinal data highlight the significant impact of adding a novel home screening test to standard lab testing, increasing opportunities for earlier identification of disease and
As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure—affecting more than 250 million people worldwide—Echosens, the
New studies presented at the American Thoracic Society (ATS) Conference this week validate e-Lung as an accurate tool to identify progressive pulmonary fibrosis Brainomix, a
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new strategic collaboration to advance
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine collaboration in March
Fuel up with free Health Tech Insights
